Form 4 for ELV Elevance Health
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001156039-24-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-15 | ELV | Neri Antonio F | Dir | A - Grant | $0.00 | +388 | 4,324 | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | A | A | 388 | $0.00 | 4,324 | D | — | — | (F2) The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. (F1) Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. |